COVID-19 Vaccine Response in Allo-HSCT Recipients: Insights from a Real-World Prospective Cohort Study

<b>Background:</b> Allogeneic hematopoietic stem cell transplant (Allo-HSCT) recipients are still at increased risk of severe COVID-19 infection. Vaccination is a critical strategy to protect this population. This real-world prospective cohort study aimed to evaluate the immune response and clinical...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Emine Merve Savaş, Şeyma Yıldız, Zübeyde Nur Özkurt, Zehra Baltacı, Özlem Güzel Tunçcan, Zeynep Arzu Yeğin, Kayhan Çağlar, Nurdan Köktürk, Gonca Erbaş, Gülendam Bozdayı, Münci Yağcı
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2025-07-01
Serija:	Vaccines
Teme:	Allo-HSCT COVID-19 vaccination antibody response immunosuppression
Online dostop:	https://www.mdpi.com/2076-393X/13/7/726
Oznake:	Označite Brez oznak, prvi označite!